家 » 全部 » 库存预测 » Summit Therapeutics Inc. Common Stock 预报

Summit Therapeutics Inc. Common Stock 预报: 明天, 下周, 下个月, 5年

已更新: April 22 · 2026 at 07:03 UTC

From

▲ +5.02%Market Cap $20.47B · Technical analysis Bullish · Focus area Price + volatility

预测总结

大体时间	预计价格	过去的	历史	洞察力
明天	$26.80 ▲ +1.59%	昨天	$26.20 ▼ -0.67%	Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
下周	$27.69 ▲ +4.95%	上星期	$25.83 ▼ -2.08%	The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
下个月	$29.16 ▲ +10.54%	上个月	$25.21 ▼ -4.43%	The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
明年	$31.37 ▲ +18.93%	去年	$24.28 ▼ -7.95%	The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年	$36.56 ▲ +38.57%	5年前	$22.11 ▼ -16.20%	The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

明天$26.80▲ +1.59%

昨天$26.20▼ -0.67%

Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.

下周$27.69▲ +4.95%

上星期$25.83▼ -2.08%

The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.

下个月$29.16▲ +10.54%

上个月$25.21▼ -4.43%

The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

明年$31.37▲ +18.93%

去年$24.28▼ -7.95%

The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5年$36.56▲ +38.57%

5年前$22.11▼ -16.20%

The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

价格走势图

历史预报看涨看跌

技术分析

Bullish

看涨

中性的

看跌

关键指标

指标	价值	信号
Price	$26.38	Mid
Daily Change	+5.02%	Above
Volatility Cap	20.0%	Mid
Confidence	68%	Above
Data Source	nasdaq-screener	Mid

史料

Current$26.38

Daily Change+5.02%

Market Cap$20.47B

Sourcenasdaq-screener

Current	$26.38	Daily Change	+5.02%
Market Cap	$20.47B	Source	nasdaq-screener

支撑位和阻力位

$25.59Support 1

$26.38当前

$27.17Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

价格里程碑

关键层面和历史背景

Current$26.38Live reference price

Used as the anchor for generated forecast calculations.

Next Month$29.16Model projection+10.54%

Directional scenario based on capped drift.

预测准确度

我们的模型表现如何

68%

定向

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

我们的算法每周使用最新的价格行为、波动机制和指标信号进行重新校准。准确性因时间范围而异——短期势头比长期预测更可靠。

Short term

68%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

投资场景

如果您今天投资 $1,000 于 SMMT

Bullish Scenario

$27.70

+5.00% from current

目标价格$27.70

设想Upside momentum

可能性60%

Base Scenario

$29.16

+10.54%

目标价格$29.16

设想Capped drift

可能性68%

Bearish Scenario

$25.06

-5.00% from current

目标价格$25.06

设想Volatility drawdown

可能性32%

基础: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

预测因素

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 72/100

24H drift+1.59%

7D drift+4.95%

30D drift+10.54%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 69/100

1M outlook+10.54%

1Y outlook+18.93%

5Y outlook+38.57%

常见问题解答

Q What is the Summit Therapeutics Inc. Common Stock (SMMT) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Summit Therapeutics Inc. Common Stock is projected near $26.80 versus the current reference around $26.38. That implies a modeled move of +1.59% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for SMMT?

The weekly Summit Therapeutics Inc. Common Stock model points to $27.69, which maps to an expected drift of +4.95% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Summit Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Summit Therapeutics Inc. Common Stock 1-month target is $29.16 (+10.54%), while the 1-year target is $31.37 (+18.93%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Summit Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Summit Therapeutics Inc. Common Stock long-horizon scenario sits near $36.56 with a modeled change of +38.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are SMMT support and resistance zones right now?

For Summit Therapeutics Inc. Common Stock, nearest resistance is around $25.59, while nearest support is around $27.17. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Summit Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.